Medium materiality4/10
Leerink raises Labcorp price target to $410
Why it may matterVerify against the original reporting
Moderately bullish, tempered by the lower target published by another firm the same day.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Leerink Partners raised its LH price target from $365 to $410, about 13% above the posted price of $363.32. Another same-day update set a lower $380 target, so analyst views are not uniform.
- Leerink raised its target $45 to $410.
- A separate same-day target is $380.
- Leerink target is about 13% above posted price.
Key facts
- 01
Target: $410
- 02
Posted price: $363.32
- 03
Analyst firm: Leerink Partners
- 04
Analyst: Michael Cherny
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.